The RETRAIN Trial (Phase 1)

Launched by COUNTESS OF CHESTER NHS FOUNDATION TRUST · Sep 25, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult over 18
• • Patient with ischaemic stroke diagnosis confirmed by a stroke physician.
• • No intracerebral haemorrhage as ruled out by computerised tomography (CT) or MRI scan.
• • Able to achieve a supine, sitting and semi-sitting position of 45° with the help of another person.
• • Receiving geko™ NMES treatment as standard of care for VTE prevention
• Exclusion Criteria:
• • Inability to gain consent from the patient.
• • A transient ischaemic attack (TIA).
• • Stroke survivors with ischaemic stroke less than 7 days from onset.
• • History of epilepsy.
• • Below/above knee amputation.
• • History of established peripheral neuropathy.
• • Too unwell to participate as judged by physician.
• • Use of any other neuromodulation device that may interact with NMES